US2372661015 - Common Stock

Taking everything into account, **DAR** scores **4** out of 10 in our fundamental rating. **DAR** was compared to 90 industry peers in the **Food Products** industry. **DAR** has a medium profitability rating, but doesn't score so well on its financial health evaluation. **DAR** has a valuation in line with the averages, but on the other hand it scores bad on growth.

In the past 5 years **DAR** has always been profitable.

Each year in the past 5 years **DAR** had a positive operating cash flow.

With a **Return On Equity** value of **8.28%**, **DAR** perfoms like the industry average, outperforming **55.56%** of the companies in the same industry.

With a **Return On Invested Capital** value of **3.61%**, **DAR** perfoms like the industry average, outperforming **46.67%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.48% | ||

ROE | 8.28% | ||

ROIC | 3.61% |

ROA(3y)8.16%

ROA(5y)7.12%

ROE(3y)17.76%

ROE(5y)15.14%

ROIC(3y)7.15%

ROIC(5y)5.19%

With a decent **Operating Margin** value of **6.51%**, **DAR** is doing good in the industry, outperforming **65.56%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **DAR** has grown nicely.

In the last couple of years the **Gross Margin** of **DAR** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 6.51% | ||

PM (TTM) | 6.04% | ||

GM | 23.77% |

OM growth 3Y25.8%

OM growth 5Y21.47%

PM growth 3Y4.72%

PM growth 5Y26.07%

GM growth 3Y-0.64%

GM growth 5Y2.08%

Compared to 1 year ago, **DAR** has a worse debt to assets ratio.

An Altman-Z score of **1.85** indicates that **DAR** is not a great score, but indicates only limited risk for bankruptcy at the moment.

Looking at the **Debt to FCF ratio**, with a value of **11.27**, **DAR** is in line with its industry, outperforming **52.22%** of the companies in the same industry.

With a **Debt to Equity ratio** value of **0.97**, **DAR** is not doing good in the industry: **72.22%** of the companies in the same industry are doing better.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.97 | ||

Debt/FCF | 11.27 | ||

Altman-Z | 1.85 |

ROIC/WACC0.48

WACC7.59%

A Current Ratio of **1.57** indicates that **DAR** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.57 | ||

Quick Ratio | 0.91 |

The earnings per share for **DAR** have decreased strongly by **-52.30%** in the last year.

The **Earnings Per Share** has been growing by **50.52%** on average over the past years. This is a very strong growth

Measured over the past years, **DAR** shows a quite strong growth in **Revenue**. The Revenue has been growing by **14.91%** on average per year.

EPS 1Y (TTM)-52.3%

EPS 3Y26.21%

EPS 5Y50.52%

EPS Q2Q%-67.55%

Revenue 1Y (TTM)-13.44%

Revenue growth 3Y23.87%

Revenue growth 5Y14.91%

Sales Q2Q%-17.2%

The **Earnings Per Share** is expected to grow by **9.35%** on average over the next years. This is quite good.

EPS Next Y-36.06%

EPS Next 2Y-3.92%

EPS Next 3Y4.09%

EPS Next 5Y9.35%

Revenue Next Year-12.79%

Revenue Next 2Y-3.94%

Revenue Next 3Y-1.91%

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

With a **Price/Earnings** ratio of **16.22**, **DAR** is valued correctly.

Compared to the rest of the industry, the **Price/Earnings** ratio of **DAR** indicates a somewhat cheap valuation: **DAR** is cheaper than 75.56% of the companies listed in the same industry.

Based on the **Price/Forward Earnings** ratio of **10.17**, the valuation of **DAR** can be described as reasonable.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.22 | ||

Fwd PE | 10.17 |

Based on the **Enterprise Value to EBITDA** ratio, **DAR** is valued a bit cheaper than 66.67% of the companies in the same industry.

71.11% of the companies in the same industry are more expensive than **DAR**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 15.04 | ||

EV/EBITDA | 11.12 |

The decent profitability rating of **DAR** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.32

EPS Next 2Y-3.92%

EPS Next 3Y4.09%

No dividends for **DAR**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**DARLING INGREDIENTS INC**

NYSE:DAR (10/11/2024, 8:04:00 PM)

After market: 36.98 0 (0%)**36.98**

**+0.96 (+2.67%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap5.88B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.22 | ||

Fwd PE | 10.17 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.32

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.48% | ||

ROE | 8.28% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 6.51% | ||

PM (TTM) | 6.04% | ||

GM | 23.77% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.58

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.97 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.57 | ||

Quick Ratio | 0.91 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-52.3%

EPS 3Y26.21%

EPS 5Y

EPS Q2Q%

EPS Next Y-36.06%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-13.44%

Revenue growth 3Y23.87%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y